NL8602933A - Geneesmiddel voor het behandelen van dementie. - Google Patents

Geneesmiddel voor het behandelen van dementie. Download PDF

Info

Publication number
NL8602933A
NL8602933A NL8602933A NL8602933A NL8602933A NL 8602933 A NL8602933 A NL 8602933A NL 8602933 A NL8602933 A NL 8602933A NL 8602933 A NL8602933 A NL 8602933A NL 8602933 A NL8602933 A NL 8602933A
Authority
NL
Netherlands
Prior art keywords
dementia
medicament according
medicament
acyloxyalkanoylcholine
acid residue
Prior art date
Application number
NL8602933A
Other languages
English (en)
Dutch (nl)
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NL8602933A publication Critical patent/NL8602933A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8602933A 1985-11-19 1986-11-19 Geneesmiddel voor het behandelen van dementie. NL8602933A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60257881A JPH0733332B2 (ja) 1985-11-19 1985-11-19 痴呆症状改善・治療剤
JP25788185 1985-11-19

Publications (1)

Publication Number Publication Date
NL8602933A true NL8602933A (nl) 1987-06-16

Family

ID=17312478

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8602933A NL8602933A (nl) 1985-11-19 1986-11-19 Geneesmiddel voor het behandelen van dementie.

Country Status (12)

Country Link
US (1) US4713376A (de)
JP (1) JPH0733332B2 (de)
AU (1) AU590640B2 (de)
CA (1) CA1278519C (de)
CH (1) CH668184A5 (de)
DE (1) DE3639378A1 (de)
DK (1) DK169607B1 (de)
FR (1) FR2590170B1 (de)
GB (1) GB2184653B (de)
IT (1) IT1200041B (de)
NL (1) NL8602933A (de)
SE (1) SE469059B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
ES2162520T3 (es) * 1998-02-13 2001-12-16 Schwabe Willmar Gmbh & Co Medicamentos basados en hiperforina y/o extractos de hiperforina.
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
WO2005019157A1 (en) * 2003-08-15 2005-03-03 Patel Hasmukh B Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
US7803842B2 (en) * 2004-06-08 2010-09-28 Hass Patel Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
WO2006059252A2 (en) * 2004-11-12 2006-06-08 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
AU2005310979A1 (en) * 2004-11-16 2006-06-08 Bellus Health (International) Limited Compounds for the treatment of CNS and amyloid associated diseases
AU2005326962A1 (en) * 2004-12-22 2006-08-17 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
WO2007125385A2 (en) * 2005-12-22 2007-11-08 Neurochem (International) Limited Treatment of renal disorders, diabetic nephopathy and dyslipidemias
SI2089417T1 (sl) 2006-10-12 2015-04-30 Bhi Limited Partnership Metode, spojine, sestavki in vektorji za dostavo 3-amino-1-propansulfonske kisline
CA2673022A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
RU2459810C2 (ru) * 2007-02-07 2012-08-27 Арджента Дискавери Лтд Нападизилатная соль антагониста мускаринового м3-рецептора
TW201115409A (en) * 2009-10-29 2011-05-01 Hannspree Inc A mouse capable of generating vapor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336350A (en) * 1970-12-28 1973-11-07 Toyama Chemical Co Ltd Choline derivatives and process for producing the same
DE2425983C3 (de) * 1973-06-12 1978-09-14 Toyama Chemical Co. Ltd., Tokio Sulfonsäuresalze von Acylcholinen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzung
JPS5221490A (en) * 1975-08-12 1977-02-18 Mitsubishi Rayon Co Printing method
JPS592904B2 (ja) * 1976-09-18 1984-01-21 日本ビクター株式会社 デイスプレイ装置
JPS551251A (en) * 1978-06-20 1980-01-08 Yamaha Motor Co Ltd Brake pedal for motorcycle
JPS58180463A (ja) * 1982-04-19 1983-10-21 Toyama Chem Co Ltd ビスコリンジスルホナ−ト類の製造法

Also Published As

Publication number Publication date
DE3639378A1 (de) 1987-05-27
AU6530286A (en) 1987-05-21
GB8627484D0 (en) 1986-12-17
FR2590170B1 (fr) 1990-08-24
AU590640B2 (en) 1989-11-09
GB2184653A (en) 1987-07-01
SE8604950D0 (sv) 1986-11-19
GB2184653B (en) 1989-11-15
DK550586A (da) 1987-05-20
DK169607B1 (da) 1994-12-27
SE8604950L (sv) 1987-05-20
FR2590170A1 (fr) 1987-05-22
CA1278519C (en) 1991-01-02
DK550586D0 (da) 1986-11-18
IT8648670A0 (it) 1986-11-19
IT1200041B (it) 1989-01-05
DE3639378C2 (de) 1990-05-10
US4713376A (en) 1987-12-15
JPH0733332B2 (ja) 1995-04-12
SE469059B (sv) 1993-05-10
JPS62120317A (ja) 1987-06-01
CH668184A5 (de) 1988-12-15

Similar Documents

Publication Publication Date Title
NL8602933A (nl) Geneesmiddel voor het behandelen van dementie.
KR0150631B1 (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
US4636494A (en) Process and composition for treating disorders by administering amphetamine and choline
HU217132B (hu) Riluzol alkalmazása AIDS-szel kapcsolatos idegi rendellenességek kezelésére alkalmas gyógyszerkészítmények előállítására
EP0026223A1 (de) Verfahren und zusammensetzung zum behandeln von störungen durch verabreichung von lezithin
JP2001513506A (ja) タイプｉｉ糖尿病のクロム／ビオチン治療
JP2022523402A (ja) 術後認知機能障害の予防及び治療のための化合物
EP0437128B1 (de) Verwendung von Fluorochinolon-Derivaten zur Behandlung der Pneumocystis carinii Pneumonie
US4346084A (en) Process and composition for treating disorders by administering lithium and choline
FR2511598A1 (fr) Produit pharmaceutique contenant une substance activant la circulation sanguine, en combinaison avec un concentrat de dialyse de sang de veau deproteine
WO2017057562A1 (ja) 末梢神経障害又は脊髄損傷の治療剤及び／又は予防剤
RU2341261C2 (ru) Композиции, содержащие эпотилоны, и их применение для лечения карциноидного синдрома
KR20050119104A (ko) 치환된 퀴놀린과 치환된 디페닐설폰을 함유하는 조성물과방법
NL194430C (nl) Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking.
JPS6124377B2 (de)
EP2001555A1 (de) Verwendung von strobilurinen zur behandlung von störungen des eisen-stoffwechsels
EP0271023A2 (de) Verwendung von Dihydrophenylaminosäurederivaten und diese enthaltende Arzneimittel zur Immunmodulation und Cytostase
US20040014681A1 (en) Method for treating dermatoses and tissue damage
RU2601622C1 (ru) Средство, обладающее эндотелиопротекторным действием в условиях экспериментального сахарного диабета и нарушения мозгового кровообращения
KR20050108402A (ko) 만성 피부 질환의 치료제 및/또는 예방제
RU2061481C1 (ru) Средство, обладающее антиагрегационной активностью
DE3823345A1 (de) 6-merkaptopurin-derivate, ihre herstellung und ihre verwendung zur bekaempfung von retrovirusinfektionen
CN114615979A (zh) 用于治疗孤独症谱系障碍的伐菲德司他
DE3406837A1 (de) Arteriosklerose-arzneimittel und -prophylaktikum
JP5055474B2 (ja) 治療上の使用のためのチアゾロピリミジン

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable